HERB — Humanoid Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- $4.56m
- $4.46m
- $18.59m
Annual cashflow statement for Humanoid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2014 December 31st | 2015 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 137 | 112 | 2.99 | 3.72 | 5.31 |
| Depreciation | |||||
| Non-Cash Items | 0.93 | 1.33 | 2.59 | 2.99 | 1.79 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -82.7 | 193 | -6.42 | -4.57 | -5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 68.1 | 321 | -0.553 | 2.44 | 2.4 |
| Capital Expenditures | -61.9 | -324 | -0.335 | -0.5 | -2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -1.79 | -0.318 |
| Change in Net Investments | |||||
| Cash from Investing Activities | -61.9 | -324 | -0.335 | -2.29 | -2.32 |
| Financing Cash Flow Items | -3.41 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.9 | 2.07 | 0.211 | -0.245 | 0.661 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.569 | -10.5 | -0.461 | 0.402 | 0.424 |